Ligand Pharmaceuticals
LGND
#3601
Rank
A$5.47 B
Marketcap
A$278.32
Share price
-1.93%
Change (1 day)
42.69%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$93.08 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.25 Billion. In 2024 the company made an earning of A$8.35 Million a decrease over its 2023 earnings that were of A$96.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$93.08 M1013.82%
2024 A$8.35 M-91.37%
2023 A$96.82 M-7.59%
2022 A$0.10 B4%
2021 A$0.10 B296.42%
2020 A$25.41 M-97.97%
2019 A$1.25 B275.62%
2018 A$0.33 B237.48%
2017 A$98.85 M49.05%
2016 A$66.32 M55.41%
2015 A$42.67 M36.87%
2014 A$31.18 M29.59%
2013 A$24.06 M1309.35%
2012 A$1.7 M-43.97%
2011 A$3.04 M-113.19%
2010 -A$23.11 Million59.86%
2009 -A$14.46 Million-61.33%
2008 -A$37.38 Million-58.75%
2007 -A$90.6 Million20.52%
2006 -A$75.17 Million81.27%
2005 -A$41.47 Million
2003 -A$28.88 Million-20.6%
2002 -A$36.36 Million4.38%
2001 -A$34.84 Million-48.83%
2000 -A$68.07 Million-19.74%
1999 -A$84.82 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$46.22 Million-5.83%
1996 -A$49.08 Million136.23%
1995 -A$20.78 Million-33.97%
1994 -A$31.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.41 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$93.17 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$14.03 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$34.76 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.84 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.87 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.09 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.41 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.77 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA